日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Wild-type p53 overexpression in NPM1-mutated acute myeloid leukemia: potential implications for disease biology and therapy response

NPM1突变型急性髓系白血病中野生型p53的过表达:对疾病生物学和治疗反应的潜在影响

Barone, Paul D; Dzedzik, Siarhei; Kleinman, Ashley S; Chin, Christopher R; Meydan, Cem; Valencia, Itzel; Sugita, Mayumi; Guzman, Monica L; Fein, Joshua A; Kaner, Justin D; Desai, Pinkal; Roboz, Gail J; Melnick, Ari M; Mason, Christopher E; Patel, Sanjay S

Risk stratification of low-dose cytarabine and venetoclax in patients with AML ineligible for intensive chemotherapy

对不适合接受强化化疗的急性髓系白血病患者进行低剂量阿糖胞苷和维奈托克治疗的风险分层

Wei, Andrew H; Panayiotidis, Panayiotis; Montesinos, Pau; Laribi, Kamel; Ivanov, Vladimir; Kim, Inho; Novak, Jan; Champion, Rebecca; Fiedler, Walter; Pagoni, Maria; Bergeron, Julie; Ting, Stephen B; Hou, Jing-Zhou; Yamauchi, Takahiro; Wang, Jianxiang; Strickland, Stephen A; Savona, Michael R; Lin, Tara L; Enjeti, Anoop; Tiong, Ing Soo; Lee, Sangmin; Roboz, Gail J; Popovic, Relja; Jiang, Qi; Liu, Zihuan; Sun, Yan; Mendes, Wellington; Chyla, Brenda; DiNardo, Courtney D

Ziftomenib in Relapsed or Refractory NPM1-Mutated AML

Ziftomenib治疗复发或难治性NPM1突变型急性髓系白血病

Wang, Eunice S; Montesinos, Pau; Foran, James; Erba, Harry; Rodríguez-Arbolí, Eduardo; Fedorov, Kateryna; Heiblig, Maël; Heidel, Florian H; Altman, Jessica K; Baer, Maria R; Ades, Lionel; Pettit, Kristen; Peterlin, Pierre; Papayannidis, Cristina; Berthon, Céline; Walter, Roland B; Shah, Mithun V; Balasubramanian, Suresh; Khawandanah, Mohamad; Salamero Garcia, Olga; Bergeron, Julie; Madanat, Yazan F; Roboz, Gail J; Ulrickson, Matthew; Redner, Robert L; McCloskey, James; Pigneux, Arnaud; de la Fuente Burguera, Adolfo; Mitra, Amitava; Soifer, Harris S; Tabachri, Marilyn; Zhang, Zijing; Riches, Marcie; Corum, Daniel; Leoni, Mollie; Issa, Ghayas C; Fathi, Amir T

Olutasidenib in combination with azacitidine induces durable complete remissions in patients with relapsed or refractory mIDH1 acute myeloid leukemia: a multicohort open-label phase 1/2 trial

奥鲁西地尼联合阿扎胞苷可使复发或难治性mIDH1急性髓系白血病患者获得持久的完全缓解:一项多队列开放标签1/2期试验

Cortes, Jorge E; Roboz, Gail J; Baer, Maria R; Jonas, Brian A; Schiller, Gary J; Yee, Karen; Ferrell, P Brent; Yang, Jay; Wang, Eunice S; Blum, William G; Mims, Alice; Tian, Hua; Sheppard, Aaron; de Botton, Stéphane; Montesinos, Pau; Curti, Antonio; Watts, Justin M

Reducing clinical trial eligibility barriers for patients with MDS: an icMDS position statement

降低MDS患者参与临床试验的门槛:icMDS立场声明

Borate, Uma; Pugh, Kelly; Waller, Allyson; Welkie, Rina Li; Huang, Ying; Bewersdorf, Jan Philipp; Stahl, Maximilian; DeZern, Amy E; Platzbecker, Uwe; Sekeres, Mikkael A; Wei, Andrew H; Buckstein, Rena J; Roboz, Gail J; Savona, Michael R; Loghavi, Sanam; Hasserjian, Robert P; Fenaux, Pierre; Sallman, David A; Hourigan, Christopher S; Della Porta, Matteo Giovanni; Nimer, Stephen; Little, Richard F; Santini, Valeria; Efficace, Fabio; Taylor, Justin; Garcia-Manero, Guillermo; Odenike, Olatoyosi; Kim, Tae Kon; Halene, Stephanie; Komrokji, Rami S; Griffiths, Elizabeth A; Greenberg, Peter L; Xu, Mina L; Xie, Zhuoer; Bejar, Rafael; Sanz, Guillermo F; Patnaik, Mrinal M; Figueroa, Maria; Carraway, Hetty E; Abdel-Wahab, Omar; Starczynowski, Daniel; Padron, Eric; Boultwood, Jacqueline; Gore, Steven; Daver, Naval G; Churpek, Jane E; Majeti, Ravindra; Bennett, John M; List, Alan F; Brunner, Andrew M; Zeidan, Amer M

Long-term follow-up and combined Phase 2 results of eprenetapopt and azacitidine in patients with TP53 mutant MDS/AML

长期随访及eprenetapopt联合阿扎胞苷治疗TP53突变型MDS/AML患者的II期联合试验结果

Sallman, David A; Komrokji, Rami S; Dezern, Amy E; Sebert, Marie; Garcia-Manero, Guillermo; Rahmé, Ramy; Winer, Eric S; Lehmann-Che, Jacqueline; Roboz, Gail J; Madelaine, Isabelle; Sekeres, Mikkael A; Peterlin, Pierre; Chan, Onyee; Beyne-Rauzy, Odile; Kuykendall, Andrew; Recher, Christian; McLemore, Amy; Stamatoullas, Aspasia; Zhang, Ling; Willems, Lise; Mo, Qianxing; Raffoux, Emmanuel; Nardelli, Lisa; Berthon, Céline; Al Ali, Najla H; Quesnel, Bruno; Padron, Eric; Kantarjian, Hagop M; List, Alan F; Ades, Lionel; Lancet, Jeffrey E; Fenaux, Pierre; Cluzeau, Thomas

Oral decitabine cedazuridine with and without venetoclax in higher-risk myelodysplastic syndromes or chronic myelomonocytic leukemia: a propensity score-matched study

口服地西他滨联合或不联合维奈托克治疗高危骨髓增生异常综合征或慢性粒单核细胞白血病:一项倾向评分匹配研究

Bataller, Alex; Sasaki, Koji; Urrutia, Samuel; Montalban-Bravo, Guillermo; Bazinet, Alexandre; Chien, Kelly; Hammond, Danielle; Bouligny, Ian M; Swaminathan, Mahesh; Issa, Ghayas; Short, Nicholas; Daver, Naval; DiNardo, Courtney D; Kadia, Tapan; Jabbour, Elias; Ravandi, Farhad; Roboz, Gail J; Savona, Michael; Griffiths, Elizabeth A; McCloskey, James; Odenike, Olatoyosi; Oganesian, Aram; Keer, Harold N; Azab, Mohammad; Kantarjian, Hagop; Garcia-Manero, Guillermo

Olutasidenib alone or combined with azacitidine in patients with mutant IDH1 myelodysplastic syndrome

奥鲁西地尼单药或联合阿扎胞苷治疗IDH1突变型骨髓增生异常综合征患者

Cortes, Jorge E; Yang, Jay; Roboz, Gail J; Dinner, Shira N; Wang, Eunice S; Wei, Andrew H; Tian, Hua; di Trapani, Francois; Baer, Maria R; Donnellan, William; Watts, Justin M

Deficit accumulation frailty index and treatment tolerability in AML: data from CALGB 11001 and 11002 (Alliance)

AML 患者的缺陷累积衰弱指数和治疗耐受性:来自 CALGB 11001 和 11002(联盟)的数据

Lai, Catherine; Lee, Minji; Bobek, Olivia; Le-Rademacher, Jennifer; Mandrekar, Sumithra; Roboz, Gail J; Uy, Geoffrey L; Mandelblatt, Jeanne S; Klepin, Heidi D

Measurable residual disease (MRD) as a surrogate end point for clinical drug approval in acute myeloid leukemia (AML): Perspectives from the MRD Partnership and Alliance in AML Clinical Treatment Consortium

可测量残留病灶(MRD)作为急性髓系白血病(AML)临床药物审批的替代终点:来自 MRD 合作组织和 AML 临床治疗联盟的观点

Boyiadzis, Michael; Wei, Andrew H; Paiva, Bruno; Freeman, Sylvie D; Kaspers, Gertjan; Chyla, Brenda; Hersey, Sarah; Patel, Reshma; Maloney, Brian; Blanchet Zumofen, Marie-Helene; Van Hoef, Marlies; Wulff, Beate; Obourn, Vanessa; Patel, Shalaka; Lopes de Menezes, Daniel; Shi, Qian; Bengoudifa, Bourras-Rezki; Dimier, Natalie; Prior, Thomas J; Roboz, Gail J; Prebet, Thomas